This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase II, Randomized, Placebo-Controlled, Multi-...
Clinical trial

A Phase II, Randomized, Placebo-Controlled, Multi-Center Study To Evaluate The Safety, Tolerability, Immunogenicity, And Antiretroviral Activity Of Dermavir (Lc002) Patch In Treatment-Na�ve HIV-1-Infected Patients

Read time: 1 mins
Last updated:23rd Aug 2007
To evaluate the safety and tolerability of the DermaVir patch (LC002) in antiretroviral therapy na�ve adults infected with HIV-1. To establish a safe and well tolerated dosing regimen of the DermaVir patch (LC002) in antiretroviral therapy na�ve adults infected with HIV-1.
Category Value
Study start date 2007-08-23

View full details